- Case report
- Open Access
A rare low-grade myofibroblastic sarcoma in lower jaw with the resemblance to benign lesions
BMC Oral Health volume 22, Article number: 380 (2022)
Low-grade myofibroblastic sarcoma (LGMS) is a rare solid infiltrative soft tissue tumor with a predilection for the head and neck region.
We report the diagnostic steps of a fast-growing lesion of the lower left jaw in a 45-year-old otherwise healthy woman. A first biopsy and subsequent histopathological examination showed potential differentials of a benign myofibroma, benign nodular fasciitis or an LGMS. This diagnostic overlap was a challenge for the decision of the further treatment approach. The treatment consisted of a segmental en bloc resection of the mandible including the second premolar, first and second molar. Histopathological examination of the resected tumor confirmed an LGMS.
The histopathologic resemblance of LGMS to a range of benign and reactive tumors may lead to misdiagnosis and mistreatment. The rarity of LGMS explains the lack of established treatment protocols. This case shows the importance of adequate clinical decisions, expertise in the histopathology of rare tumors and interdisciplinary exchange to achieve state-of-the-art patient management.
Low-grade myofibroblastic sarcoma (LGMS) is a rare fibroblastic/myofibroblastic malignant tumor, distinctly classified by the World Health Organization (WHO) . It is characterized by the increased proliferation of myofibroblasts. The etiology of LGMS is unknown. This solid infiltrative soft tissue tumor occurs in various sites of the body with a predilection for the head and neck region, particularly the tongue followed by the mandible, neck, larynx, palate, maxilla and lips . Patients’ mean age is 40 years, but it has been reported in all age groups . Due to scarcity of published cases and the limited size of case series in the literature, it remains unknown if there is a gender predilection . LGMS is mostly described as a slow-growing, indolent mass and it is therefore frequently misdiagnosed initially as a benign lesion. Destructive patterns may become apparent with the radiologic examination . The histopathologic diagnosis is challenging due to the rarity of LGMS and morphologic resemblance to closely related benign lesions. The histologic appearance can vary from fasciitis-, fibromatosis- to fibrosarcoma-like patterns. LGMS has a high recurrence potential while metastatic spread occurs rarely .
A 45-year-old otherwise healthy female presented at the Department of Oral Surgery and Stomatology, University of Bern with a painful exophytic, lobulated tumor in the left posterior mandible on the lingual side. The patient had first noticed a lump two weeks ago and her dentist interpreted it as an epulis. Within 5 days, the tumor rapidly increased in size and was accompanied by pain. The patient experienced no fever, night sweats or weight loss. She denied any history of trauma. Her medical history was non-contributory and she had never smoked. The extraoral examination showed neither swelling nor facial asymmetry nor paresthesia. In the head and neck area, no clinical evidence of lymphadenopathy was observed. On clinical oral examination, the round-to-ovoid mass measured 12 × 20 mm in size and was firm to palpation, superficially ulcerated, and fixed to the underlying tissues (Fig. 1A). The first left mandibular molar showed an increased mobility, but not the premolars and the second molar. The examination with the periodontal probe showed normal pockets in the upper and lower jaw, except for the first lower molar (Fig. 1B). All teeth in the left posterior mandible were positive when testing with CO2 dry ice. The patient had a good oral hygiene. The periapical radiograph showed a bowl-shaped radiolucent area around the first molar (Fig. 2). Cone beam computed tomography (CBCT) demonstrated a radiolucent lesion on the lingual side of the first molar along and between the roots. The unilocular osteolytic area involved the marginal and lingual aspect of the bone and was fenestrated to the crestal side. The borders were ill-defined (Fig. 3). There were no signs of root resorption of the left first molar or adjacent teeth.
An incisional biopsy of the firm mass was performed with a carbon dioxide laser (Fig. 4). Histopathological examination showed a proliferation of haphazardly arranged spindle cells with high mitotic activity as well as a high degree of vascularization. A storiform and partially fasciculated architecture was found. The background was fibrous and showed partially myxoid aspects (Fig. 5A). Higher magnification revealed elongated spindle-shaped cells with longitudinal and oval-shaped, cigar shaped and slightly hyperchromic nuclei (Fig. 5B). The proliferation index Ki-67 was about 25–35%. Immunohistochemistry showed positivity for SMA, HHF35 and Calponin, but was negative for Caldesmon and Desmin (Fig. 6). As the diagnostic evaluation was challenging, the samples were sent to the DÖSAK (German-Swiss-Austrian Working Group of Maxillofacial Tumors) reference registry in Basel (Switzerland) for second opinion. The proposed differential diagnosis encompassed a benign lesion, an intermediate malignant transformation or a low-grade malignant process. The main differential diagnosis included myofibroma and LGMS, but the degree of atypia and the lack of a biphasic morphology favored LGMS.
Consequently, the pathologists recommended tumor resection with subsequent histopathological evaluation. The planning of the next therapeutic steps took a possible malignant tumor into consideration. The treatment consisted of a segmental en bloc resection of the mandible including the second premolar, the first and second molar and was performed with a sufficiently large safety margin (Fig. 7). The horizontal border of the bone resection was set immediately above the mandibular canal. The inferior alveolar nerve was preserved. In connection with the tumor removal, the remaining mandibular bone was stabilized using a 3D-Grid Plate for fracture prevention (Fig. 8). Histopathological examination of the resected tumor showed an unencapsulated, well-circumscribed mass of numerous atypical spindle cells. The mitotic rate was 5/10 high power fields. Considering the superficial ulceration, the infiltration with destruction of the underlying compact bone as well as the morphology described, the diagnosis of LGMS was confirmed (Fig. 9). Resection margins were clear.
One year after tumor resection there were no signs of recurrence. To achieve vertical bone augmentation, transplants of autologous bone from the outer table were fixed with titanium screws to the left mandible, complemented with a mixture of autologous bone, blood, bone substitute particles and covered with a resorbable membrane.
Discussion and conclusions
This case shows the challenging diagnostic and therapeutic decisions of a low-grade malignant spindle cell tumor with similarities to benign, reactive or other malignant tumors. After clinical and radiological examination, benign and malignant lesions were both possible. The differentials considered were a giant cell lesion of the jaw (GCLJ), a myofibroma, a nodular fasciitis, a squamous cell carcinoma, a lymphoma, or a metastasis. The presence of a rare tumor was also discussed. The quite well demarcated firm soft tissue mass had the appearance of a benign process, whereas its fast growth in conjunction with bony destruction and mobility of a single tooth were typical signs for malignancy. This clinical discrepancy of a possible benign or malignant lesion reinforced the importance of a biopsy. However, the histopathologic diagnosis was particularly difficult in the present case.
A common oral GCLJ is the peripheral giant cell granuloma (PGCG) or so-called giant cell epulis. Trigger factors such as dental trauma or local irritation such as chronic infections, dental plaque or food impaction as well as poorly adapted margins of restorations or orthodontic therapy have been discussed [3, 6]. Erosion of the adjacent alveolar bone has been described, but the presence of a crater-like osteolytic lesion in the radiograph was not typical for a PGCG. After histopathological examination of the first biopsy specimen a GCLJ was ruled out.
Another reactive process is nodular fasciitis, first described by Konwaler in 1955 and often found in the subcutaneous fascia of adults aged between 20 to 40 years [1, 7]. The head and neck region is affected in 20% of all cases, but lesions in the oral cavity are rare. . The histopathology of a nodular fasciitis shows a variably cellular fibroblastic and myofibroblastic proliferation, arranged in short irregular fascicles, growing in a so-called cell culture pattern, sometimes with a high mitotic index. The presence of prominent vasculature and extravasated red blood cells can be helpful in differentiation from other myofibroblastic lesions. Clinically and histologically, nodular fasciitis can be misdiagnosed as a sarcoma. A rearrangement of the USP6 gene is commonly found and can be of great diagnostic help in difficult cases [1, 3]. The clinical context of the case presented here fitted well with a nodular fasciitis: a rapidly growing tumor-like mass, increasing pain and no evidence of systemic disease. The clinical appearance alone was, however, not reliable for diagnosis . Nodular fasciitis is self-limited and often a spontaneous regression can be observed. Incisional biopsy with histopathological examination remains essential for the diagnosis and subsequent procedure.
The myofibroma is a rare benign soft-tissue neoplasm of the head and neck region and affects mostly the mandible, the tongue or the buccal mucosa. A genetic predisposition and factors such as trauma and injury have been discussed in the literature [10, 11]. The myofibroma is a fairly indolent slow-growing firm mass with lobulated surface, but cases with rapid and aggressive growth have also been described. It can present intraosseous as well-defined, unilocular radiolucency, mainly in the posterior mandible . Not in accordance with the present case is that 75% of the patients are younger than 20 years of age . Histopathologically, a myofibroma is an unencapsulated, well-demarcated biphasic lesion composed of myofibroblasts. Tumor cells are spindle shaped with scant cytoplasm and sometimes showing a zoning phenomenon .
The most frequent malignant tumor affecting the oral cavity is in 90% of cases a squamous cell carcinoma (SCC) [13, 14]. Predilections sites for SCC in the oral cavity are the tongue and floor of the mouth, but all sites can be involved, including the gingiva and alveolar ridge. The prevalence of SCC on the gingiva has been reported in 14%  in a multicenter study including populations from Canada, Korea, Iran, Taiwan and Thailand to 32%  in a population from Lagos in Nigeria. The clinical findings of the present case with rapid growth of a tumor mass, superficial ulceration, as well as the infiltration of the alveolar bone were suspicious for an SCC. Atypical, however, was the mesio-distal symmetrical shape of the tumor mass and the intact mucosa to the caudal. The absence of risk factors such as tobacco and alcohol use as well as the age of the patient were also considered as unusual.
Lymphoma are the third most common malignancies in the oral cavity and the diffuse large B cell lymphoma not otherwise specified (DLBCL NOS) is most often diagnosed. DLBCL NOS can arise in patients without risk factors and 40% are extranodal. A rapid growing soft tissue tumor typically located at the palate or the gingiva or alveolar ridge is a typical sign. Some cases involving the alveolar bone have been described in the literature [16, 17].
Another consideration was the presence of an intraoral metastasis. In early stages, mucosal metastases present as exophytic, most often on the gingiva. Jawbone metastases are more frequently found in the mandible than the maxilla and the most common site is the molar area. Overall, metastatic dissemination is rarely found in the oral cavity  and the presented patient had no cancer history.
The histopathologic diagnosis was essential, but also difficult in the present case. Potential differential diagnoses like a PCLJ, an SCC or a lymphoma were easily ruled out histopathologically, whereas myofibromas, nodular fasciitis and an LGMS show a significant morphologic overlap. After the first biopsy this overlap and potential differential diagnoses were a challenge for the subsequent treatment approach. In the case of a benign tumor or reactive lesion, a highly invasive therapy should be avoided to minimize the patient’s morbidity and subsequent impact on quality of life. On the other hand, overlooking and not rapidly and adequately treating a malignant tumor can be fatal. Furthermore, there is a lack of immunohistochemical and molecular markers that differentiate a myofibroma from an LGMS with certainty. Chromosomal imbalances have been described in myofibroblastic sarcoma and, in a small case series, these genetic aberrations were occurring more often compared to nodular fasciitis . However, the methods of detection have their limitations and it is not an established method used to identify malignancy of a tumor. The histopathologic resemblance of LGMS to a myofibroma and fibromatosis is often likely a source of diagnostic confusion. Furthermore, the possibility of a lack of experience of the clinician and/or the pathologist due to the rarity of these pathologies further complicates the matter .
In the present case, the amount of cellular atypia together with the locally aggressive and symptomatic growth (bone erosion, surface ulceration), were very suspicious for an LGMS. For this reason, a more radical treatment approach with extraction of teeth and adequate bone resection was suggested to the patient and subsequently performed by the maxillofacial surgeon. The histopathological analysis of the resected specimen showed the invasive growth of the tumor into the bone and together with the high mitotic rate confirmed the diagnosis of a LGMS. The margins of resection were tumor free.
The complete clinical picture of LGMS remains unclear. Often LGMS is a slow-growing and indolent tumor [4, 21, 22]. This is in contrast to our case. It is assumed that LGMS occurs far more often than the scarcity of reported cases might portray. While most studies reported the head and neck region, including oral cavity, as predilection sites, the incidence of LGMS in other regions of the body could be higher than expected as shown by one of the latest studies .
Wide tumor excision including surrounding tissue is the suggested therapy. A recent case series showed the association between local recurrence and the tissue invasion of LGMS as well as the surgical method. Resection margins > 2 cm are suggested to minimize the risk of recurrence . However, wider safety margins are often more problematic in the oral cavity than in other parts of the body, such as the extremities. A histopathological confirmation of tumor-free margins is requested and ideally already available during the surgery, but does not exclude recurrence [23, 25]. Some authors have recommended an adjuvant chemotherapy and radiotherapy. The latter is controversial as it is supposed to even induce poorer prognosis, with a reported recurrence rate of 18.8% following surgery only and 71.4% after surgery and radiotherapy . Definitive treatment criteria, treatment protocols and requirements are still undetermined and require further research.
While the potential for recurrence of LGMS is high, the risk of metastasis is low [21, 22, 24]. In an earlier case series, only one patient with multiple distant soft-tissue, intraosseous and pulmonary metastases after a long time interval was described. Thus, it seems appropriate to classify these neoplasms as malignancy . However, a more recent case series observed a higher rate of metastasis than earlier studies. It could also be assumed, that recurrent cases are more prone to present as intermediate and high-grade, but this has not been observed .
This case shows the diagnostic and therapeutic challenge of a rare low-grade myofibroblastic sarcoma and the team approach of clinicians and pathologists alike in order to achieve state-of-the-art patient management.
Availability of data and materials
Low-grad myofibroblastic sarcoma
World Health Organization
Giant cell lesion of the jaw
Peripheral giant cell granuloma
Squamous cell carcinoma
Cone beam computed tomography
- DLBCL NOS:
Diffuse large B cell lymphoma not otherwise specified
German-Swiss-Austrian Working Group of Maxillofacial Tumors
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumors, 5th ed. Lyon, France: IARC; 2020
Maruyama T, Nakasone T, Nimura F, Matayoshi A, Kawano T, Nishihara K, et al. Indolent growth of low-grade myofibroblastic sarcoma of the cheek mimics benign lesions: a case report and literature review. Oncol Lett. 2017;13:4307–14.
El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors’ perspectives. Hum Pathol. 2017;66:10–2.
Chan JYK, Gooi Z, Wong EWY, Ng SK, Tong MCF, Vlantis AC. Low-grade myofibroblastic sarcoma: a population-based study. Laryngoscope. 2017;127(1):116–21.
Demarosi F, Bay A, Moneghini L, Carrassi A. Low-grade myofibroblastic sarcoma of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2009;108:248–54.
Lester SR, Cordell KG, Rosebush MS, Palaiologou AA, Maney P. Peripheral giant cell granulomas: a series of 279 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:475–82.
Konwaler BE, Keasbey L, Kaplan L. Subcutaneous pseudosarcomatous fibromatosis (Fasciitis). Am J Clin Pathol. 1955;25:241–52.
Naidu A, Lerman MA. Clinical pathologic conference case 3: nodular fasciitis. Head Neck Pathol. 2011;5(3):276–80.
Dayan D, Nasrallah V, Vered M. Clinico-pathologic correlations of myofibroblastic tumors of the oral cavity: I. Nodular fasciitis. J Oral Pathol Med. 2005;34(7):426–35.
Lingen MW, Mostofi RS, Solt DB. Myofibromas of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 1995;80:297–302.
Smith MH, Reith JD, Cohen DM, Islam NM, Sibille KT, Bhattacharyya I. An update on myofibromas and myofibromatosis affecting the oral regions with report of 24 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:62–75.
Foss RD, Ellis GL. Myofibromas and myofibromatosis of the oral region: a clinicopathologic analysis of 79 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:57–65.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.
Effiom OA, Adeyemo WL, Omitola OG, Ajayi OF, Emmanuel MM, Gbotolorun OM. Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria. J Oral Maxillofac Surg. 2008;66:1595–9.
Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M, et al. Oral cancer: a multicenter study. Med Oral Patol Oral y Cir Bucal. 2018;23(1):e23–9.
Rodrigues-Fernandes CI, de Souza LL, Santos-Costa SFD, Pontes HAR, de Almeida OP, Vargas PA, Henao JR, Rahimi S, Brennan PA, Fonseca FP. Clinicopathological analysis of oral diffuse large B-cell lymphoma, NOS: a systematic review. J Oral Pathol Med. 2019;48(3):185–91.
de Arruda JAA, Schuch LF, Conte Neto N, de Souza LL, Rodrigues-Fernandes CI, Abreu LG, Soares CD, de Carvalho MGF, Agostini M, de Andrade BAB, Romañach MJ, Zanella VG, Barra MB, Martins MD, Souto GR, Etges A, Pontes HAR, Pontes FSC, Vargas PA, de Almeida OP, Santos-Silva AR, Lopes MA, Pires FR, Gomez RS, Fonseca FP, Mesquita RA. Oral and oropharyngeal lymphomas: a multi-institutional collaborative study. J Oral Pathol Med. 2021;50(6):603–12.
Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.
Meng GZ, Zhang HY, Zhang Z, Wei B, Bu H. Myofibroblastic sarcoma vs nodular fasciitis a comparative study of chromosomal imbalances. Am J Clin Pathol. 2009;131:701–9.
Patel VA, Naqvi A, Koshal S. A benign, low-grade myofibroblastic lesion mimicking a sarcoma. J Surg Case Rep. 2020;2020:rjaa020.
Montgomery E, Goldblum JR, Fisher C. Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol. 2001;25(2):219–28.
Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22(10):1228–38.
Kim J-H, Choi W, Cho HS, Lee KS, Park JK, Kim B-K. Surgical treatment and long-term outcomes of low-grade myofibroblastic sarcoma: a single-center case series of 15 patients. World J Surg Oncol. 2021;19(1):1–7.
Yamada T, Yoshimura T, Kitamura N, Sasabe E, Ohno S, Yamamoto T. Low-grade myofibroblastic sarcoma of the palate. Int J Oral Sci. 2012;4:170–3.
Wang L, Li LX, Chen DQ, Yang L, Li SK, Cheng C. Low-grade Myofibroblastic sarcoma: clinical and imaging findings. BMC Med Imag. 2019;19(1):1–9.
Ethics approval and consent to participate
For a case report ethical approval is not required at our institution and is exempted from approval by the cantonal Ethics Committee and swissethics.
Consent for publication
Written informed consent was obtained from the patient for publication of her clinical details and any accompanying images. A copy of the written consent is available on request. All of the data were anonymized.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Schwerzmann, M.C., Dettmer, M.S., Baumhoer, D. et al. A rare low-grade myofibroblastic sarcoma in lower jaw with the resemblance to benign lesions. BMC Oral Health 22, 380 (2022). https://doi.org/10.1186/s12903-022-02381-1
- Diagnostic challenge
- Low-grade-myofibroblastic sarcoma
- Malignant spindle cell tumor